N05CD02 |
NITRAZEPAM |
SOMNITE |
RO-53059 |
RO-4-5360 |
UNISOMNIA |
NSC-58775 |
MOGADON |
REMNOS |
RO-5-3059 |
RO-45360 |
NITRADOS |
IMESON |
1,3-DIHYDRO-7-NITRO-5-PHENYL-2H-1,4-BENZODIAZEPIN-2-ONE |
RELACT |
GERSON |
BENZALIN (TN) |
NEOZEPAM |
NEUCHLONIC |
HIPSAL |
NITRAZEPAMUM |
PERSOPIT |
SONNOLIN |
PAXISYN |
7-NITRO-1,3-DIHYDRO-5-PHENYL-2H-1,4-BENZODIAZEPIN-2-ONE |
EATAN |
7-NITRO-5-PHENYL-2,3-DIHYDRO-1H-1,4-BENZODIAZEPIN-2-ONE |
APODORM |
SOMITRAN |
HIPNAX |
BENZALIN |
RADEDORM |
RO 5-3059 |
RO 4-5360 |
IMESONT |
PELSON |
IBROVEK |
SONEBON |
NELMAT |
CALSMIN |
N-DESMETHYLNIMETAZEPAM |
EUNOCTIN |
TRAZENIN |
2,3-DIHYDRO-7-NITRO-5-PHENYL-1H-1,4-BENZODIAZEPIN-2-ONE |
NELBON |
SUREM |
ATEMPOL |
chembl:CHEMBL13209 |
pubchem.compound:4506 |
chemidplus:146-22-5 |
rxcui:7440 |
drugbank:01595 |
Drug Class | anticonvulsants |
Drug Class | hypnotics and sedatives |
Year of Approval | not approved by the fda |
FDA Approval | not approved by the FDA |
Drug Class | small molecule |
Drug Indications | Hypnotics and Sedatives |
Drug Indications | Anticonvulsants |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Novel drug target | Established target |
Trial Name | - |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Novel drug target | Established target |
Trial Name | - |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Novel drug target | Established target |
Trial Name | - |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
other/unknown |
Trial Name | - |
Novel drug target | Established target |
NITRAZEPAM | Primary Drug Name |
Year of Approval | not approved by the fda |
Drug Class | hypnotics and sedatives |
Drug Class | anticonvulsants |
Drug Indications | Anticonvulsants |
Drug Indications | Hypnotics and Sedatives |
Drug Class | small molecule |
D0T5WK | TTD Drug ID |
CHEMBL13209 | ChEMBL Drug ID |